Spruce Biosciences, Inc.
SPRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001683553
No open-market purchases or sales by Spruce Biosciences, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $116.3M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Spruce Biosciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 43 | 2 | 38 | −3 |
| Shares | 17.1M | 28.5K | 16.4M | −684.4K (−4.0%) |
| Value | $34.4M | $57.0K | $28.5M | −$5.80M (−16.9%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Spruce Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 190,147 | $331.0K | 0.00% |
| Ergoteles LLC | 41,900 | $73.0K | 0.00% |
| Virtu Financial LLC | 15,738 | $27.0K | 0.00% |
| StoneX Group Inc. | 11,900 | $20.7K | 0.00% |
| Federated Hermes, Inc. | 988 | $2.00K | 0.00% |
| Credit Suisse AG | 5 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 119 | $0 | 0.00% |
Sold out (10)
Institutions that held Spruce Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Charles Schwab Investment Management Inc | 18,417 | $38.0K |
| State Board of Administration of Florida Retirement System | 17,440 | $35.0K |
| Cubist Systematic Strategies, LLC | 13,202 | $27.0K |
| Deutsche Bank AG | 12,297 | $24.0K |
| Nuveen Asset Management, LLC | 11,643 | $24.0K |
| American International Group, Inc. | 4,312 | $9.00K |
| California State Teachers Retirement System | 3,936 | $8.00K |
| Point72 Hong Kong Ltd | 2,881 | $6.00K |
| Amalgamated Bank | 1,084 | $2.00K |
| Ameritas Investment Partners, Inc. | 584 | $1.00K |
Not filed for Q2 2022 yet (2)
Institutions that held Spruce Biosciences, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 27,424 | $55.0K |
| Amalgamated Financial Corp. | 1,084 | $2.00K |